That "article" said nothing. It was written like a 2nd grade book report. Not one iota of information about WHY they might be so positioned. And from we have read, I believe they are having problems with the Chinese in connection with a patent for their drug, so there is nothing imminent that we know of. Leronlimab has the best safety profile out there and if it is found to work for conronavirus...